SCIENTIFIC PROGRAMME

Final Programme (PDF) 


 SESSION 1: STARTING FROM BASIC SCIENCE
 Chair: Francesco BLASI (Italy)
14.00-15.00 What is COPD: is it a disease or a syndrome?
Klaus RABE (Germany)
Discussant: Guy BRUSSELLE (Belgium)
15.00-15.40 COPD: what are we learning from basic science / immunology?
Louise DONNELLY (UK)
Discussion: Peter CALVERLEY (UK)
15.40-16.10 Will stem cells deliver lung regeneration?
Geoffrey LAURENT (Australia)
16.10-16.40 Novel theraupetic agents in COPD
Gabriella MATERA (Italy)
Discussant: Clive PAGE (UK)
16.40-17.00 Coffee break
 SESSION 2: COPD PATHOPHYSIOLOGY
Chair: Stefano CENTANNI (Italy)
17.00-17.30 COPD: from imaging to function?
Massimo PISTOLESI (Italy)
17.30-18.00 POLYVALENT MECHANICAL BACTERIAL LYSATE AS A
POTENTIALLY EFFECTIVE APPROACH IN PREVENTING ACUTE
EXACERBATIONS OF COPD
Chair: Fulvio BRAIDO (Italy)
Mario CAZZOLA (Italy)
18.00-19.00 A DISCUSSION ON USE OF PROs (patient reported outcomes)
PROs a new outcome evaluation in clinical trials
Fulvio BRAIDO (Italy)
PROs: gaps and limits
Peter CALVERLEY (UK)
19.00-19.30 OPENING LECTURE 
Prevention and Control of COPD in Low resource setting: Package of Essential Intervention for Primary Health Care
Talant M.SOORONBAEV (Kyrgyz Republic)
19.30-20.30 OPENING RECEPTION

 SESSION 3: COPD PATHOPHYSIOLOGY
Chair: Antonio TORRES (Spain)
08.30-09.15 Mild COPD: how to define it? Do we have to treat it?
Pro: Guy BRUSSELLE (Belgium)
Con: Pierluigi PAGGIARO (Itlay)
 SESSION 4: EXACERBATION IN THE NATURAL HISTORY OF COPD
Chair: Tobias WELTE (Germany)
09.15-10.00 Frequent Exacerbation: a real phenotype?
Pro: Guy JOOS (Belgium)
Con: Antonio TORRES (Spain) 
10.00-10.45 Antibiotic prophylaxis: If, Why, When and How?
Wisia WEDZICHA (UK)
10.45-11.15 Bronchiectasis and COPD: what’s new?
Miguel Angel MARTINEZ-GARCIA (Spain)
11.15-11.30 Coffee break
 SESSION 5: FROM RECOMMENDATIONS TO CLINICAL PRACTICE
11.30-12.15 What we learned from large clinical trials in COPD
Peter CALVERLEY (UK)
12.15-13.15 Comparative history and evolution of guidelines
Marc MIRAVITLLES (Spain)
13.15-14.30 Lunch and Mentor – Young researchers discussion
14.30-15.30 NEW STRATEGIES FOR PATIENT-CENTERED COPD MANAGEMENT
14.30-14.35 Chair’s introduction
Francesco BLASI (Italy)
14.35-14.50 The role of bronchodilators and ICS in COPD stages
Marc MIRAVITLLES (Spain)
14.50-15.15 Combined bronchodilation improves COPD outcomes
Wisia WEDZICHA (UK)
15.15-15.25 Q&A session
15.25-15.30 Conclusions
Francesco BLASI (Italy)
 SESSION 6: COPD and COMORBIDITIES
Chair: Antonio TORRES (Spain)
15.30-16.15 Impact of comorbidities on the natural history of COPD
Leonardo FABBRI (Italy)
Discussion: Nicholas ROCHE (France)
16.15-16.45 Anxiety and depression in COPD
Stefano CENTANNI (Italy)
16.45-17.15 Treating COPD beyond the lines
Mario CAZZOLA (Italy)
17.15-17.45 Coffee break
17.45-18.45 COPD: A NEW VISION
Moderator: Alberto PAPI (Italy)
Phenotyping COPD patients: a step forward?
Massimo PISTOLESI (Italy)
Phenotyping COPD patients: a new approach for treatment?
Francesco BLASI (Italy)

08.00-09.30 POSTER SESSION
 SESSION 7: COPD: The Lung and the others
Chair: Antonio TORRES (Spain)
09.30-10.00 Heart – Lung Interaction
Pier Giuseppe AGOSTONI (Italy)
10.00-10.30 NIV the state of the art Stefano ALIBERTI (Italy)
 SESSION 8: COPD and Childhood: roles of the recurrent infections
Chairs: Diana BILTON (UK), Antonio TORRES (Spain)
10.30-11.00 The role of recurrent infectionsSusanne ESPOSITO (Italy)
11.00-11.30 Coffee break
 SESSION 9: SEVERE COPD EXACERBATION: lateral thinking
Chair: Stefano CENTANNI (Italy)
11.30-12.00 Severe COPD exacerbations: something more than mechanical
ventilation
Luciano GATTINONI (Italy)
12.00-13.00 Conclusion – Final wrap up and Poster Awards
Chairs: Francesco BLASI (Italy), Tobias WELTE (Germany)
Antonio TORRES (Spain)
Final wrap up and Poster Awards
Final wrap up and Poster Awards